Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Patient-reported quality of life in Chinese children with B-cell acute lymphoblastic leukemia receiving first-line treatment with blinatumomab

Jia Fan, Mengjia Liu, Peijing Qi, Wei Lin, Ying Wu, Jiaole Yu, Yuanyuan Zhang, Pengli Huang, Huyong Zheng, Ruidong Zhang

Blood (2025) 146 (Supplement 1): 1551.

https://doi.org/10.1182/blood-2025-1551

Published: 2025

Journal Articles

Efficacy and safety of blinatumomab as frontline treatment for infant acute lymphoblastic leukemia

Jie Yang, Wei Lin, Jia Fan, Jiaole Yu, Ying Wu, Yuanyuan Zhang, Ruidong Zhang

Blood (2025) 146 (Supplement 1): 6860.

https://doi.org/10.1182/blood-2025-6860

Published: 2025

Journal Articles

Exploring the immunodynamic landscape of blinatumomab therapy in pediatric BCP-ALL through full-spectrum flow cytometry

Mingying Zhang, Wei Lin, Ying Wu, Peijing Qi, Yuanyuan Zhang, Jiaole Yu, Pengli Huang, Jia Fan, Ruidong Zhang

Blood (2025) 146 (Supplement 1): 1597.

https://doi.org/10.1182/blood-2025-1597

Published: 2025

Journal Articles

Single-Cell Sequencing Analysis Reveals Cellular Dynamics Underlying Different Responses to Blinatumomab in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Mingying Zhang, Yuanyuan Zhang, Peijing Qi, Wei Lin, Ying Wu, Jiaole Yu, Huyong Zheng, Ruidong Zhang

Blood (2024) 144 (Supplement 1): 4214.

https://doi.org/10.1182/blood-2024-204307

Published: 2024

Journal Articles

Full-Spectrum Flow Cytometry Analysis Reveals Dynamics of T Cell Function of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia during Continuous Infusion of Blinatumomab

Mingying Zhang, Yuanyuan Zhang, Peijing Qi, Wei Lin, Ying Wu, Jiaole Yu, Huyong Zheng, Ruidong Zhang

Blood (2024) 144 (Supplement 1): 5922.

https://doi.org/10.1182/blood-2024-209220

Published: 2024

Journal Articles

Inequalities in Treatment Utilization Among Older Medicare Beneficiaries with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Induction Therapy

Amer M. Zeidan, Yanqing Xu, Tatyana A. Kapustyan, Kaylee Miu, Cheng Chen, Rajesh Kamalakar, Chia-Wei Lin, Esprit Ma, Melissa Montez, Zheng Wu, Tracy Yee, Haiyan Sun, Andrew Rava, Sonia Kim, Scott F Huntington

Blood (2024) 144 (Supplement 1): 3795.

https://doi.org/10.1182/blood-2024-200213

Published: 2024

Journal Articles

Efficacy and Safety of Adding Blinatumomab to First-Line Treatment for Chinese Children with B-Cell Acute Lymphoblastic Leukemia

Peijing Qi, Yuanyuan Zhang, Ying Wu, Jiaole Yu, Jia Fan, Wei Lin, Huyong Zheng, Ruidong Zhang

Blood (2024) 144 (Supplement 1): 312.

https://doi.org/10.1182/blood-2024-199937

Published: 2024

Journal Articles

Cost-Effectiveness of Emicizumab Vs Efanesoctocog Alfa, Standard Half Life (SHL) and Other Extended Half Life (EHL) FVIII Products for Prophylaxis in People with Severe Hemophilia a without Inhibitors

Randall Curtis, Marquita Decker-Palmer, Michele R Wilson, Cheryl L McDade, Chia-Wei Lin, Chris Wallick, Richard H Ko

Blood (2023) 142 (Supplement 1): 5053.

https://doi.org/10.1182/blood-2023-181062

Published: 2023

Journal Articles

Cost-Effectiveness of Emicizumab for Prophylaxis in People with Severe Hemophilia A without Inhibitors

Marquita Decker-Palmer, Chia-Wei Lin, Michele Wilson, Cheryl McDade, Komal Bawa, Stacey Kowal, Arliene Ravelo, Elaine Yu, Richard H. Ko

Blood (2022) 140 (Supplement 1): 13041–13042.

https://doi.org/10.1182/blood-2022-162276

Published: 2022

Journal Articles

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Blood (2022) 140 (Supplement 1): 3189–3191.

https://doi.org/10.1182/blood-2022-165737

Published: 2022

Journal Articles

Patient-Reported Outcomes Among Adults with Hemophilia A on Prophylactic Treatment

Janet Chupka, Marquita Decker-Palmer, Chia-Wei Lin, Ashley Martin, Kushal Modi, Dawn Bates, Karen Thomson

Blood (2022) 140 (Supplement 1): 10893–10894.

https://doi.org/10.1182/blood-2022-159064

Published: 2022

Journal Articles

E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia

Wen-Chieh Pi, Jun Wang, Miho Shimada, Jia-Wei Lin, Huimin Geng, Yu-Ling Lee, Rui Lu, Dongxu Li, Gang Greg Wang, Robert G. Roeder, Wei-Yi Chen

Blood (2020) 136 (1): 11–23.

https://doi.org/10.1182/blood.2019003312

Published: 2020

Includes: Supplemental data

Journal Articles

A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in Combination with Daratumumab As a Salvage Regimen for Multiple Myeloma

Nina D. Shah, MD, Cameron J. Turtle, MBBS, PhD, Andrew J. Cowan, MD, Julio C. Chavez, MD, Lihua E Budde, MD PhD, Mario Q. Marcondes, MD PhD, Zachary Lee, PharmD, Wei Lin, MD, Jonathan Zalevsky, Mary Tagliaferri, MD, Krina K. Patel, MDMSc

Blood (2019) 134 (Supplement_1): 4459.

https://doi.org/10.1182/blood-2019-122494

Published: 2019

Journal Articles

Pilot Study on the Safety of Intravenous Arsenic Trioxide and Oral Realgar-Indigo Naturalis Formula Administrated in Children with Acute Promyelocytic Leukemia: A Single-Center Study

Linya Wang, MD, Yuanyuan Zhang, MD, Ruidong Zhang, MD PhD, Jiaole Yu, PhD MD, Ying Wu, MD, Wei Lin, Peijing Qi, Jia Fan, Jing Li, PhD, Jiayan Lin, Xueling Zheng, Hairu Hu, Xiaoxia Peng, Hui Jiang, PhD, Huyong Zheng, MD PhD

Blood (2019) 134 (Supplement_1): 2611.

https://doi.org/10.1182/blood-2019-128196

Published: 2019

Journal Articles

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Yuan Li, MD, Qing Ya Wang, MD, Ze Yin Liang, Yue Yin, Wei Liu, MD PhD, Qian Wang, Yujun Dong, MD, YuHua Sun, Wei Lin Xu, Hanyun Ren, MD PhD

Blood (2019) 134 (Supplement_1): 5647.

https://doi.org/10.1182/blood-2019-125275

Published: 2019

Journal Articles

Clinical Characteristics & Outcome of Adolescent Patients with Acute Lymphoblastic Leukemia

Jiaole Yu, PhD MD, Ruidong Zhang, MD PhD, Jing Xie, MD, Yuanyuan Zhang, MD, Ying Wu, MD, Chao Gao, Wei Lin, Huyong Zheng, MD PhD

Blood (2017) 130 (Supplement 1): 5007.

https://doi.org/10.1182/blood.V130.Suppl_1.5007.5007

Published: 2017

Journal Articles

Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma

Chia-Jen Liu, MD, Pei Hsu, MD, Ting-Wei Lin, MD, Jyh-Pyng Gau, MD, Liang-Tsai Hsiao, MD, Cheng-Hwai Tzeng, MD, Po-Min Chen, MD, Yuan-Bin Yu, MD, Tzeon-Jye Chiou, MD, Yao-Chung Liu, MD, Jing-Hwang Liu, MD

Blood (2015) 126 (23): 5306.

https://doi.org/10.1182/blood.V126.23.5306.5306

Published: 2015

Journal Articles

Manumycin Induces Apoptosis of Leukemic Stem Cells Through Down-Regulation of Bcl2

Miaorong She, Jinggao Li, Xilin Chen, Xin Du, PhD, Wei Lin, Zesheng Lu, Yanjie He, Kunyuan Guo

Blood (2011) 118 (21): 4738.

https://doi.org/10.1182/blood.V118.21.4738.4738

Published: 2011

Journal Articles

Human γδ T lymphocytes induce robust NK cell–mediated antitumor cytotoxicity through CD137 engagement

Amudhan Maniar, Xiaoyu Zhang, Wei Lin, Brian R. Gastman, C. David Pauza, Scott E. Strome, Andrei I. Chapoval

Blood (2010) 116 (10): 1726–1733.

https://doi.org/10.1182/blood-2009-07-234211

Published: 2010

Includes: Supplemental data

Journal Articles

A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma

Ying-Wei Lin, Zanna M. Beharry, Elizabeth G. Hill, Jin H. Song, Wenxue Wang, Zuping Xia, Zhenhua Zhang, Peter D. Aplan, Jon C. Aster, Charles D. Smith, Andrew S. Kraft

Blood (2010) 115 (4): 824–833.

https://doi.org/10.1182/blood-2009-07-233445

Published: 2010

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Patient-reported quality of life in Chinese children with B-cell acute lymphoblastic leukemia receiving first-line treatment with blinatumomab

Efficacy and safety of blinatumomab as frontline treatment for infant acute lymphoblastic leukemia

Exploring the immunodynamic landscape of blinatumomab therapy in pediatric BCP-ALL through full-spectrum flow cytometry

Single-Cell Sequencing Analysis Reveals Cellular Dynamics Underlying Different Responses to Blinatumomab in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Full-Spectrum Flow Cytometry Analysis Reveals Dynamics of T Cell Function of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia during Continuous Infusion of Blinatumomab

Inequalities in Treatment Utilization Among Older Medicare Beneficiaries with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Induction Therapy

Efficacy and Safety of Adding Blinatumomab to First-Line Treatment for Chinese Children with B-Cell Acute Lymphoblastic Leukemia

Cost-Effectiveness of Emicizumab Vs Efanesoctocog Alfa, Standard Half Life (SHL) and Other Extended Half Life (EHL) FVIII Products for Prophylaxis in People with Severe Hemophilia a without Inhibitors

Cost-Effectiveness of Emicizumab for Prophylaxis in People with Severe Hemophilia A without Inhibitors

Homoharringtonine-Based Induction Regimens Combined with ATRA-Based Maintenance in Chinese Pediatric AML: A Report from the Cclg-AML 2015 Protocol Study

Patient-Reported Outcomes Among Adults with Hemophilia A on Prophylactic Treatment

E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia

A Phase 1, Open-Label, Multi-Center, Dose Escalation and Dose Expansion Study of NKTR-255 As a Single Agent in Relapsed or Refractory Hematologic Malignancies and in Combination with Daratumumab As a Salvage Regimen for Multiple Myeloma

Pilot Study on the Safety of Intravenous Arsenic Trioxide and Oral Realgar-Indigo Naturalis Formula Administrated in Children with Acute Promyelocytic Leukemia: A Single-Center Study

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Clinical Characteristics & Outcome of Adolescent Patients with Acute Lymphoblastic Leukemia

Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma

Manumycin Induces Apoptosis of Leukemic Stem Cells Through Down-Regulation of Bcl2

Human γδ T lymphocytes induce robust NK cell–mediated antitumor cytotoxicity through CD137 engagement

A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only